Stefan Harmsen
Overview
Explore the profile of Stefan Harmsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
792
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Faber R, Baart V, Bordo M, March T, Valentijn A, Harmsen S, et al.
Toxicol Appl Pharmacol
. 2025 Jan;
495:117222.
PMID: 39742926
Introduction: Accurate staging of malignancies often requires comprehensive evaluation of lymph nodes. However, finding these lymph nodes during oncological surgery is a daunting and time-consuming task, which increases the risk...
2.
Hart M, Isuri R, Ramos D, Osharovich S, Rodriguez A, Harmsen S, et al.
Chem Biomed Imaging
. 2024 Jul;
2(7):490-500.
PMID: 39056064
Lung cancer, the most common cause of cancer-related death in the United States, requires advanced intraoperative detection methods to improve evaluation of surgical margins. In this study we employed DDAO-arachidonate...
3.
Karsalia R, Zhou C, Muhammad N, Teng C, Singh Y, Huang V, et al.
Clin Neurol Neurosurg
. 2024 Jun;
243:108385.
PMID: 38878642
Objective: Surgery remains the first line treatment for meningiomas and can benefit from fluorescence-guided surgical techniques such as second-window indocyanine green (SWIG). In the current study, we compared the use...
4.
Karsalia R, Cheng N, Teng C, Cho S, Harmsen S, Lee J
Neurosurg Focus Video
. 2022 Oct;
6(1):V8.
PMID: 36284582
A prospective trial evaluating the utility of second window indocyanine green (SWIG) in predicting postoperative MRI gadolinium enhancement was performed on high-grade gliomas (HGGs) and brain metastases. Compared to white...
5.
De Ravin E, Venkatesh S, Harmsen S, Delikatny E, Husson M, Lee J, et al.
Am J Otolaryngol
. 2022 Aug;
43(5):103570.
PMID: 35939987
Objective: To assess the feasibility and effectiveness of indocyanine green (ICG) for image-guided resection of head and neck cancer (HNC). Data Sources: PubMed, Embase, and Scopus databases. Review Methods: Searches...
6.
Watson D, Harmsen S
Nanotheranostics
. 2022 Jan;
6(1):118-120.
PMID: 34976585
No abstract available.
7.
Andreiuk B, Nicolson F, Clark L, Panikkanvalappil S, Kenry , Rashidian M, et al.
Nanotheranostics
. 2022 Jan;
6(1):10-30.
PMID: 34976578
Surface-enhanced Raman spectroscopy (SERS) nanotags hold a unique place among bioimaging contrast agents due to their fingerprint-like spectra, which provide one of the highest degrees of detection specificity. However, in...
8.
Plakas K, Rosch L, Clark M, Adbul-Rashed S, Shaffer T, Harmsen S, et al.
Nanotheranostics
. 2022 Jan;
6(1):1-9.
PMID: 34976577
Surface enhanced Raman scattering (SERS) is proving to be a useful tool for biomedical imaging. However, this imaging technique can suffer from poor signal-to-noise ratio, as the complexity of biological...
9.
Aras O, Harmsen S, Ting R, Sayman H
Acta Radiol Open
. 2021 Jun;
10(5):20584601211022509.
PMID: 34104479
Targeted radionuclide therapy has emerged as a promising and potentially curative strategy for high-grade prostate cancer. However, limited data are available on efficacy, quality of life, and pretherapeutic biomarkers. Here,...
10.
Aras O, Demirdag C, Kommidi H, Guo H, Pavlova I, Aygun A, et al.
Clin Genitourin Cancer
. 2021 Apr;
19(5):405-416.
PMID: 33879400
Background: A first-in-human study of [F]-BF3-Cy3-ACUPA, a small-molecule imaging agent that can be unimolecularly both positron emitting and fluorescent, is conducted to determine its safety, biodistribution, radiation dosimetry, feasibility in...